Business ❯ Pharmaceutical Industry ❯ Drug Development

Regulatory Affairs

FDA Regulations FDA Approval Eli Lilly and Company Licensing Agreements European Commission Approval Market Authorization Novo Nordisk NDA Process FDA Approval Process Drug Approval

Fulcrum Halts Pociredir Development After FDA Flags PRC2 Cancer Risk

The FDA concluded PRC2-targeting therapies carry similar cancer risks, leaving no viable regulatory path for pociredir.

Novo Nordisk’s Oral Semaglutide Lowers HbA1c in Teens in Pivotal Trial

For Third Time, FDA Rejects Aldeyra’s Dry-Eye Drug Reproxalap Over Efficacy

FDA Rejects Disc Medicine’s Bitopertin for EPP After Questioning Surrogate Endpoint